BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36269280)

  • 1. Endothelial CYP2J2 overexpression restores the BRB via METTL3-mediated ANXA1 upregulation.
    Zhao B; Huang J; Lou X; Yao K; Ye M; Mou Q; Wen Z; Duan Q; Zhang H; Zhao Y
    FASEB J; 2022 Nov; 36(11):e22619. PubMed ID: 36269280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.
    Díaz-Coránguez M; Lin CM; Liebner S; Antonetti DA
    J Biol Chem; 2020 Apr; 295(14):4647-4660. PubMed ID: 32086377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy.
    Rudraraju M; Narayanan SP; Somanath PR
    Pharmacol Res; 2020 Nov; 161():105115. PubMed ID: 32750417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the p75 neurotrophin receptor using LM11A-31 prevents diabetes-induced retinal vascular permeability in mice via inhibition of inflammation and the RhoA kinase pathway.
    Elshaer SL; Alwhaibi A; Mohamed R; Lemtalsi T; Coucha M; Longo FM; El-Remessy AB
    Diabetologia; 2019 Aug; 62(8):1488-1500. PubMed ID: 31073629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmalemma Vesicle-Associated Protein Has a Key Role in Blood-Retinal Barrier Loss.
    Wisniewska-Kruk J; van der Wijk AE; van Veen HA; Gorgels TG; Vogels IM; Versteeg D; Van Noorden CJ; Schlingemann RO; Klaassen I
    Am J Pathol; 2016 Apr; 186(4):1044-54. PubMed ID: 26878208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions.
    Klaassen I; Van Noorden CJ; Schlingemann RO
    Prog Retin Eye Res; 2013 May; 34():19-48. PubMed ID: 23416119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of endothelium-specific CYP2J2 overexpression on the attenuation of retinal ganglion cell apoptosis in a glaucoma rat model.
    Huang J; Zhao Q; Li M; Duan Q; Zhao Y; Zhang H
    FASEB J; 2019 Oct; 33(10):11194-11209. PubMed ID: 31295013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.
    Vinores SA; Youssri AI; Luna JD; Chen YS; Bhargave S; Vinores MA; Schoenfeld CL; Peng B; Chan CC; LaRochelle W; Green WR; Campochiaro PA
    Histol Histopathol; 1997 Jan; 12(1):99-109. PubMed ID: 9046048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor ligand-related molecule 1A maintains blood-retinal barrier via modulating SHP-1-Src-VE-cadherin signaling in diabetic retinopathy.
    Li J; Xie R; Jiang F; Li Y; Zhu Y; Liu Z; Liao M; Liu Y; Meng X; Chen S; Yu J; Du M; Wang X; Chen Y; Yan H
    FASEB J; 2021 Nov; 35(11):e22008. PubMed ID: 34679191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management.
    Kaur C; Foulds WS; Ling EA
    Prog Retin Eye Res; 2008 Nov; 27(6):622-47. PubMed ID: 18940262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats.
    Fan Y; Liu K; Wang Q; Ruan Y; Ye W; Zhang Y
    Exp Eye Res; 2014 Oct; 127():104-16. PubMed ID: 24910901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
    Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin A1 nuclear translocation induces retinal ganglion cell apoptosis after ischemia-reperfusion injury through the p65/IL-1β pathway.
    Zhao Y; Li X; Gong J; Li L; Chen L; Zheng L; Chen Z; Shi J; Zhang H
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1350-1358. PubMed ID: 28389361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cKit Inhibitor, Masitinib, Prevents Diabetes-Induced Retinal Vascular Leakage.
    Kim SR; Im JE; Jeong JH; Kim JY; Kim JT; Woo SJ; Sung JH; Park SG; Suh W
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1201-6. PubMed ID: 26978025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
    Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
    Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids exert differential effects on the endothelium in an in vitro model of the blood-retinal barrier.
    van der Wijk AE; Canning P; van Heijningen RP; Vogels IMC; van Noorden CJF; Klaassen I; Schlingemann RO
    Acta Ophthalmol; 2019 Mar; 97(2):214-224. PubMed ID: 30168271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of plasmalemma vesicle-associated protein in pathological breakdown of blood-brain and blood-retinal barriers: potential novel therapeutic target for cerebral edema and diabetic macular edema.
    Bosma EK; van Noorden CJF; Schlingemann RO; Klaassen I
    Fluids Barriers CNS; 2018 Sep; 15(1):24. PubMed ID: 30231925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PHD2 attenuates high-glucose-induced blood retinal barrier breakdown in human retinal microvascular endothelial cells by regulating the Hif-1α/VEGF pathway.
    Li J; Lu X; Wei L; Ye D; Lin J; Tang X; Cui K; Yu S; Xu Y; Liang X
    Inflamm Res; 2022 Jan; 71(1):69-79. PubMed ID: 34773469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
    Kim JH; Kim JH; Yu YS; Cho CS; Kim KW
    J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.